Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001620834 | SCV001843113 | benign | not provided | 2020-02-24 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002539567 | SCV003321847 | benign | Rubinstein-Taybi syndrome | 2023-05-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002539566 | SCV003685565 | likely benign | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003966257 | SCV004789551 | likely benign | CREBBP-related disorder | 2022-02-23 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |